DBV Technologies S.A. (DBV.PA)

EUR 0.61

(1.17%)

Inventory Summary of DBV Technologies S.A.

  • DBV Technologies S.A.'s latest annual inventory in 2023 was 1.00 USD , up 100.0% from previous year.
  • DBV Technologies S.A.'s latest quarterly inventory in 2024 Q2 was 1.00 EUR , down -100.0% from previous quarter.
  • DBV Technologies S.A. reported annual inventory of -11.2 Million USD in 2022, up 65.99% from previous year.
  • DBV Technologies S.A. reported annual inventory of -32.93 Million USD in 2021, down -1141.62% from previous year.
  • DBV Technologies S.A. reported quarterly inventory of 1.72 Million USD for 2024 Q1, down -17.88% from previous quarter.
  • DBV Technologies S.A. reported quarterly inventory of -15.28 Million USD for 2023 Q2, down -749.66% from previous quarter.

Annual Inventory Chart of DBV Technologies S.A. (2023 - 2011)

Historical Annual Inventory of DBV Technologies S.A. (2023 - 2011)

Year Inventory Inventory Growth
2023 1.00 USD 100.0%
2022 -11.2 Million USD 65.99%
2021 -32.93 Million USD -1141.62%
2020 3.16 Million EUR 38.51%
2019 2.28 Million EUR 27.44%
2018 1.79 Million EUR -27.3%
2017 2.46 Million EUR 0.0%
2016 - EUR -100.0%
2015 2.02 Million EUR 1240.62%
2014 150.87 Thousand EUR 1563.49%
2013 9069.57 EUR -76.89%
2012 39.24 Thousand EUR -12.11%
2011 44.64 Thousand EUR 0.0%

Peer Inventory Comparison of DBV Technologies S.A.

Name Inventory Inventory Difference
ABIONYX Pharma SA 221 Thousand EUR 100.0%
ABIVAX Société Anonyme 1.00 EUR 0.0%
Adocia SA 272 Thousand EUR 100.0%
Aelis Farma SA 53 Thousand EUR 99.998%
Biophytis S.A. - EUR -Infinity%
Advicenne S.A. 1.74 Million EUR 100.0%
genOway Société anonyme 982.75 Thousand EUR 100.0%
IntegraGen SA 311.44 Thousand EUR 100.0%
Medesis Pharma S.A. 164.62 Thousand EUR 99.999%
Neovacs S.A. - EUR -Infinity%
NFL Biosciences SA -1.1 Million EUR 100.0%
Plant Advanced Technologies SA 1.22 Million EUR 100.0%
Quantum Genomics Société Anonyme -119.17 Thousand EUR 100.001%
Sensorion SA - EUR -Infinity%
Theranexus Société Anonyme - EUR -Infinity%
TME Pharma N.V. 91 Thousand EUR 99.999%
Valbiotis SA 1 Million EUR 100.0%
TheraVet SA 123.34 Thousand EUR 99.999%
Valerio Therapeutics Société anonyme 1.00 EUR 0.0%
argenx SE 281.12 Million EUR 100.0%
BioSenic S.A. - EUR -Infinity%
Celyad Oncology SA 1.26 Million EUR 100.0%
Galapagos NV 73.97 Million EUR 100.0%
Genfit S.A. 4000.00 EUR 99.975%
GeNeuro SA - EUR -Infinity%
Hyloris Pharmaceuticals SA 1.00 EUR 0.0%
Innate Pharma S.A. 1.00 EUR 0.0%
Inventiva S.A. 417 Thousand EUR 100.0%
MaaT Pharma SA 190 Thousand EUR 99.999%
MedinCell S.A. -6.71 Million EUR 100.0%
Nanobiotix S.A. 200 Thousand EUR 100.0%
Onward Medical N.V. 936 Thousand EUR 100.0%
Oryzon Genomics S.A. 6029.00 EUR 99.983%
OSE Immunotherapeutics SA - EUR -Infinity%
Oxurion NV 128 Thousand EUR 99.999%
Pharming Group N.V. 51.38 Million EUR 100.0%
Poxel S.A. 2.95 Million EUR 100.0%
GenSight Biologics S.A. 1.00 EUR 0.0%
Transgene SA - EUR -Infinity%
Financière de Tubize SA - EUR -Infinity%
UCB SA 1.03 Billion EUR 100.0%
Valneva SE 44.46 Million EUR 100.0%
Vivoryon Therapeutics N.V. 1.00 EUR 0.0%